| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |